SolventumRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Solventum (SOLV) reported revenue of $2.21B in Q2 2026, with MedSurg its largest revenue segment at 65%.
SolventumSolventum makes wound-care and infection-prevention products, dental materials, and health-information software. It was spun out of 3M on April 1, 2024 and keeps its principal office at the 3M Center in Maplewood, Minnesota.
Solventum (SOLV) is a Health Care Technology company. Solventum makes wound-care and infection-prevention products, dental materials, and health-information software. It was spun out of 3M on April 1, 2024 and keeps its principal office at the 3M Center in Maplewood, Minnesota. It was founded in 2023, is headquartered in Maplewood, Minnesota and employs about 20,000 people.
As of 2026-Q2, Solventum's revenue breaks down across MedSurg (65%), Dental Solutions (19%), Health Information Systems (17%). See the revenue-by-segment chart for the full mix.
Track Solventum's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated August 26, 2026.
Sterling groups Solventum in the Healthcare sector, alongside Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW) and GE HealthCare (GEHC).
If you are researching Solventum, also look at Abbott Laboratories (ABT), Baxter International (BAX) and Becton Dickinson (BDX). You can compare all of them side by side or browse the full Healthcare sector on Sterling.
Q2 2023-Q2 2026(All available data)
Q1 2022-Q2 2026(All available data)